New methods to help the body accept heart transplants without ongoing medication
New Approaches to Inducing Cardiac Allograft Tolerance
This study is looking at new ways to help people who receive heart transplants accept their new heart without needing to take medicine that suppresses their immune system all the time, using a special combination of donor bone marrow and kidney transplants.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10889209 on NIH RePORTER |
What this research studies
This research focuses on achieving long-term acceptance of heart transplants without the need for continuous immunosuppressive drugs. It explores innovative protocols that have successfully induced tolerance in heart transplant recipients using a combination of donor bone marrow and kidney transplants in animal models. The approach aims to enhance the body's regulatory mechanisms to accept the transplanted heart, potentially leading to better outcomes for patients. By studying these methods, the research seeks to overcome the challenges associated with heart transplantation, which is often resistant to tolerance compared to other organs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are undergoing or are candidates for heart transplantation.
Not a fit: Patients who are not candidates for heart transplantation or those with contraindications for the procedures involved may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the need for lifelong immunosuppressive therapy in heart transplant recipients, improving their quality of life and reducing complications.
How similar studies have performed: Previous research has shown success in achieving tolerance in kidney transplants, but this approach for heart transplants is novel and has not been widely tested in clinical settings.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Madsen, Joren C — Massachusetts General Hospital
- Study coordinator: Madsen, Joren C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.